The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) contract to Telix Pharmaceuticals US Inc. for the provision of various radiopharmaceuticals. The single-award BPA has a ceiling value of $4,498,000.00 and a period of performance from October 1, 2023 through September 30, 2028.
Under this BPA, the VA VHA has issued a $910,000.00 firm fixed price BPA Call Order to Telix Pharmaceuticals US Inc. for the base period from October 1, 2023 through September 30, 2024. The BPA Call Order is for the supply of radiopharmaceuticals, to be performed in Fishers, Indiana. Telix Pharmaceuticals US Inc. will serve as the prime contractor, with no small business set-asides or subcontractors indicated. The radiopharmaceuticals procured under this contract support the VA's nuclear medicine and medical imaging services for veterans across the country.
Generated 9/24/24, 9:09 AM